BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3131380)

  • 1. Peptide histidine methionine may be a prolactin-releasing hormone in humans.
    Sasaki A; Sato S; Shinkawa O; Go M; Otsuka T; Sugawara A; Shimizu Y; Murakami O; Hanew K; Andoh N
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1202-7. PubMed ID: 3131380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution, plasma concentration, and in vivo prolactin-releasing activity of peptide histidine methionine in humans.
    Sasaki A; Sato S; Go MG; Shimizu Y; Murakami O; Hanew K; Yumita S; Andoh N; Sasano N; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Oct; 65(4):683-8. PubMed ID: 3654914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactive corticotropin-releasing hormone, growth hormone-releasing hormone, somatostatin, and peptide histidine methionine are present in adrenal pheochromocytomas, but not in extra-adrenal pheochromocytoma.
    Sasaki A; Yumita S; Kimura S; Miura Y; Yoshinaga K
    J Clin Endocrinol Metab; 1990 Apr; 70(4):996-9. PubMed ID: 1969422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin responsiveness to peptide histidine methionine-27 in normal subjects and hyperprolactinemic patients.
    Muratori M; Romano C; Gambino G; Faglia G
    Horm Res; 1994; 42(6):257-61. PubMed ID: 7698720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of peptide histidine methionine (PHM) on corticotropin-releasing hormone (CRH) induced ACTH secretion in humans.
    Sasaki A; Sato S; Go M; Murakami O; Hanew K; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1305-7. PubMed ID: 2824555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H; Tamura T
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide histidine methionine and vasoactive intestinal peptide levels in human cerebrospinal fluid: age-related changes and absence of a correlation with serum prolactin.
    Yasuda M; Minamitani N; Maeda K; Chihara K; Fujita K; Kobayashi I
    Regul Pept; 1993 Jul; 46(3):565-73. PubMed ID: 8210516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anomalous growth hormone response to vasoactive intestinal peptide and peptide histidine methionine in patients with prolactinoma or hypothalamic hyperprolactinemia.
    Watanobe H; Tamura T; Takahashi K
    Neuropeptides; 1994 Aug; 27(2):137-42. PubMed ID: 7991068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of involvement of the cholinergic mechanism in vasoactive intestinal peptide- and peptide-histidine methionine-induced growth hormone (GH) responses in acromegaly: comparison with the GH responses to thyrotropin-releasing hormone and GH-releasing hormone.
    Watanobe H; Habu S; Nasushita R; Takebe K
    Neuropeptides; 1994 Aug; 27(2):85-90. PubMed ID: 7991070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical response of growth hormone to peptide histidine methionine in acromegaly: comparison with the effects of thyrotropin-releasing hormone and vasoactive intestinal peptide.
    Watanobe H; Sasaki S; Sone K; Takebe K
    J Clin Endocrinol Metab; 1991 May; 72(5):982-5. PubMed ID: 1902488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome.
    Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR
    J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin, vasoactive intestinal peptide, and peptide histidine methionine elicit selective increases in REM sleep in rabbits.
    Obal F; Opp M; Cady AB; Johannsen L; Krueger JM
    Brain Res; 1989 Jun; 490(2):292-300. PubMed ID: 2765864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin gene expression and secretion during pregnancy and lactation in the rat: role of dopamine and vasoactive intestinal peptide.
    Escalada J; Cacicedo L; Ortego J; Melian E; Sánchez-Franco F
    Endocrinology; 1996 Feb; 137(2):631-7. PubMed ID: 8593812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactive corticotropin-releasing hormone present in human plasma may be derived from both hypothalamic and extrahypothalamic sources.
    Sasaki A; Sato S; Murakami O; Go M; Inoue M; Shimizu Y; Hanew K; Andoh N; Sato I; Sasano N
    J Clin Endocrinol Metab; 1987 Jul; 65(1):176-82. PubMed ID: 3294879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple forms of immunoreactive growth hormone-releasing hormone in human plasma, hypothalamus, and tumor tissues.
    Sasaki A; Sato S; Yumita S; Hanew K; Miura Y; Yoshinaga K
    J Clin Endocrinol Metab; 1989 Jan; 68(1):180-5. PubMed ID: 2491860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of prolactin-releasing factor in the rat posterior pituitary.
    Hyde JF; Ben-Jonathan N
    Endocrinology; 1988 Jun; 122(6):2533-9. PubMed ID: 3131118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative importance of vasoactive intestinal peptide and peptide histidine isoleucine as physiological regulators of prolactin in the domestic turkey.
    Kulick RS; Chaiseha Y; Kang SW; Rozenboim I; El Halawani ME
    Gen Comp Endocrinol; 2005 Jul; 142(3):267-73. PubMed ID: 15935152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infusion of prepro-VIP derived peptides in man: effect on secretion of prolactin.
    Yiangou Y; Gill JS; Chrysanthou BJ; Burrin J; Bloom SR
    Neuroendocrinology; 1988 Dec; 48(6):615-8. PubMed ID: 3251160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulatory effect of peptide histidine isoleucine amide 1-27 on prolactin release in the rat.
    Kaji H; Chihara K; Abe H; Minamitani N; Kodama H; Kita T; Fujita T; Tatemoto K
    Life Sci; 1984 Aug; 35(6):641-7. PubMed ID: 6431217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional distribution of human growth hormone-releasing hormone in the human hypothalamus by radioimmunoassay.
    Leidy JW; Robbins RJ
    J Clin Endocrinol Metab; 1986 Feb; 62(2):372-8. PubMed ID: 3079775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.